EN PL

EMEA: Guideline on the Development of Medicinal Products for the Treatment of Post-Traumatic Stress Disorder (PTSD)

16.02.2009
EMEA:
Guideline on the Development of Medicinal Products for the Treatment of Post-Traumatic Stress Disorder (PTSD). This document provides guidance to Marketing Authorisation Applicants (MAAs) and Marketing Authorisation Holders (MAHs) on various methodological aspects related to studies aimed at investigating the efficacy and safety of products for the treatment of PTSD. See also: Overview of comments on the above (24 July 2008)